QuidelOrtho Corporation (QDEL)

NMS – Real vaqt narxi. Valyuta: USD

14.62

+0.63 (4.52%)

Bozor ochiq: Aug 12, 2026, 2:26 PM EDT

13.72

-0.27 (-1.93%)

Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT

10.08.2026

QDEL Q2 Earnings & Revenues Beat Estimates, 2026 Guidance Lowered

QuidelOrtho beats Q2 earnings and revenue estimates, but cuts its 2026 outlook on persistent China weakness and a softer respiratory testing environment.

07.08.2026

QuidelOrtho Corporation (QDEL) Q2 2026 Earnings Call Transcript

07.08.2026

QuidelOrtho Q2 Earnings Call Highlights

QuidelOrtho NASDAQ: QDEL reported second-quarter revenue growth despite continued pressure from China and a softer respiratory testing environment, while lowering its full-year outlook and withdrawing free cash flow guidance.

06.08.2026

QuidelOrtho (QDEL) Surpasses Q2 Earnings and Revenue Estimates

QuidelOrtho (QDEL) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to earnings of $0.12 per share a year ago.

06.08.2026

QuidelOrtho Reports Second Quarter 2026 Financial Results

― Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ― ― Excluding China, total revenue grew 6% both as reported and in constant currency ― ― Company updates full-year 2026 financial guidance ― SAN DIEGO, Aug. 6, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a leading global provider of diagnostic solutions, today announced financial results for the second quarter ended June 28, 2026. Key Second Quarter 2026 Results: (all comparisons are to the prior year period) Total revenue was $631 million, an increase of 3% as reported and 2% in constant currency.

05.08.2026

Implied Volatility Surging for QuidelOrtho Stock Options

Investors need to pay close attention to QDEL stock based on the movements in the options market lately.

QuidelOrtho Corporation (QDEL)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

QuidelOrtho Corporation (QDEL)

QDEL Q2 Earnings & Revenues Beat Estimates, 2026 Guidance Lowered

QuidelOrtho Corporation (QDEL) Q2 2026 Earnings Call Transcript

QuidelOrtho Q2 Earnings Call Highlights

QuidelOrtho (QDEL) Surpasses Q2 Earnings and Revenue Estimates

QuidelOrtho Reports Second Quarter 2026 Financial Results

Implied Volatility Surging for QuidelOrtho Stock Options

QDEL Q2 Earnings & Revenues Beat Estimates, 2026 Guidance Lowered

QuidelOrtho Corporation (QDEL) Q2 2026 Earnings Call Transcript

QuidelOrtho Q2 Earnings Call Highlights

QuidelOrtho (QDEL) Surpasses Q2 Earnings and Revenue Estimates

QuidelOrtho Reports Second Quarter 2026 Financial Results

Implied Volatility Surging for QuidelOrtho Stock Options

Videolar

No Data

Press-relizlar

QuidelOrtho Reports Second Quarter 2026 Financial Results

Search stocks

QuidelOrtho Corporation (QDEL)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

QuidelOrtho Corporation (QDEL)

QDEL Q2 Earnings & Revenues Beat Estimates, 2026 Guidance Lowered

QuidelOrtho Corporation (QDEL) Q2 2026 Earnings Call Transcript

QuidelOrtho Q2 Earnings Call Highlights

QuidelOrtho (QDEL) Surpasses Q2 Earnings and Revenue Estimates

QuidelOrtho Reports Second Quarter 2026 Financial Results

Implied Volatility Surging for QuidelOrtho Stock Options

QDEL Q2 Earnings & Revenues Beat Estimates, 2026 Guidance Lowered

QuidelOrtho Corporation (QDEL) Q2 2026 Earnings Call Transcript

QuidelOrtho Q2 Earnings Call Highlights

QuidelOrtho (QDEL) Surpasses Q2 Earnings and Revenue Estimates

QuidelOrtho Reports Second Quarter 2026 Financial Results

Implied Volatility Surging for QuidelOrtho Stock Options

Videolar

No Data

Press-relizlar

QuidelOrtho Reports Second Quarter 2026 Financial Results